WELL Health Technologies Corp.
TSX:WELL.TOMedical - Care Facilities
+$0.02 today
- Market cap
- $947.00M
- Beta
- 1.33
- P/E (TTM)
- 41.6
- EPS (TTM)
- $0.11
Volume 2.80M
Average 1.62M
WELL.TO Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
WELL Health Technologies Corp.TSX: WELL.TO
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows in line with its trailing trend
Q1 FY2026 depreciation & amortization of CA$25.57M rose 30.8% year over year, behind the +32.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 14.7% from the prior quarter. Over 3 fiscal years it compounded at +19.3% a year.
Context
- Depreciation & amortization amounted to 6.7% of revenue in FY2025, down 1.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +30.8% toward the trailing-twelve-month pace of +32.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
CAD · from the cash flow
- Latest · FY2025
- 93.76M CAD
- Year-over-year change
- +29.7%
- 4-year CAGR
- +25.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 93.76M | +29.7% |
| FY2024 | 2024-12-31 | 72.31M | +19.0% |
| FY2023 | 2023-12-31 | 60.77M | +10.1% |
| FY2022 | 2022-12-31 | 55.2M | +44.4% |
| FY2021 | 2021-12-31 | 38.22M | — |
Depreciation & Amortization vs competitors
How WELL.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +32.5% is the 2nd highest of 5, against a peer median of +7.3%.
- Depreciation & amortization amounts to 6.8% of revenue for WELL.TO, versus a peer median of 4.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$99.79M CAD | +32.5% | +19.3% | 6.8% | |
| LTM Sep 2026 | CA$58.16M CAD | +5.0% | +7.8% | 5.2% | |
| LTM Jun 2026 | CA$46.46M CAD | +37.1% | +5.1% | 2.3% | |
| LTM Mar 2026 | $13.77M USD | -26.6% | -9.0% | 4.5% | |
| LTM Mar 2026 | $11.45M USD | +9.6% | +3.3% | 7.2% | |
| Peer median (excluding WELL.TO) | — | +7.3% | +4.2% | 4.9% | |
Competitors are the stored peer set for WELL.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (30.9M) | 18.68M | 82K | 29.1M | 4.46M |
| Depreciation & Amortization | 38.22M | 55.2M | 60.77M | 72.31M | 93.76M |
| Deferred Income Tax | 1.04M | (978K) | (10.42M) | (31.62M) | (16.38M) |
| Stock-Based Compensation | 21.01M | 24.48M | 26.16M | 15.27M | 22.69M |
| Change in Working Capital | (11.2M) | (6.06M) | (10.25M) | 6.67M | (36.7M) |
| Accounts Receivables | (13.27M) | (9.37M) | (2.49M) | (80.25M) | 47.3M |
| Inventory | 876K | (577K) | 190K | (1.51M) | 231K |
| Accounts Payables | 1.6M | 10.55M | (9.21M) | 36.42M | (20.12M) |
| Other Working Capital | (399K) | (6.67M) | 1.26M | 52.02M | (64.12M) |
| Other Non-Cash Items | 4.1M | (14.78M) | 95K | (82.21M) | 47.96M |
| Operating Cash Flow | 22.27M | 76.55M | 66.44M | 9.52M | 115.79M |
| Capital Expenditures | (2.68M) | (6.4M) | (25.38M) | (16.23M) | (27.87M) |
| Acquisitions (Net) | (421.76M) | (31.13M) | (72.78M) | (37.27M) | (80.51M) |
| Purchases of Investments | (3.12M) | (16.51M) | 0 | (73K) | 0 |
| Sales of Investments | 3.12M | 16.51M | 11.56M | 2.39M | 15.1M |
| Other Investing Activities | (75.33M) | (396K) | (19.82M) | (9.05M) | (18.47M) |
| Investing Cash Flow | (499.78M) | (37.93M) | (106.42M) | (60.23M) | (111.74M) |
| Debt Repayment | 171.07M | (58.75M) | 38.77M | (49.34M) | 157.6M |
| Common Stock Issued | 302.5M | 34.51M | 810K | 3.22M | 445K |
| Common Stock Repurchased | 0 | (243K) | 0 | (1.66M) | (1.83M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (21.04M) | 6.15M | (28.14M) | 136.85M | (155.28M) |
| Financing Cash Flow | 452.53M | (52.85M) | 10.63M | 133.5M | 941K |
| Effect of Forex Changes | 9K | 1.22M | (532K) | 4.75M | (2.91M) |
| Net Change in Cash | (24.97M) | (13.01M) | (5.49M) | 88.25M | 2.09M |
| Free Cash Flow | 19.59M | 70.14M | 37.2M | (6.7M) | 87.92M |
WELL Health Technologies Corp.
TSX:WELL.TO
Intrinsic Alpha fair value
Locked
Current Price
$3.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.